Basic Information


GTO ID GTC0903
Trial ID ChiCTR2000041025
Disease Hematologic Cancer
TherapyCAR-T cell
Treatment CAR-T cells
PhaseEarly_Phase1
Recruitment statusRecruiting
TitleCAR-T cells in the treatment of relapsed and refractory hematological malignancies
Year2020
CountryCHINA
Company sponsorTianjin First Central Hospital

Clinical Result

Cohort 1
Administration route None
Pts 20

Relationship Graph

Overview of Knowledge Graph